The Next Generation of Pharmaceutical Research for Neurology
The Next Generation of Pharmaceutical Research for Neurology
Embedded Files
Over 90% of neurological drugs fail to make it though human clinical trials.
Why? Most preclinical results from lab rats don't translate well to humans.
Epiloid Biotechnology is a biotechnology research organization,
specializing in preclinical 3D human cerebral organoid assays
for novel neurological pharmaceuticals.
Pre-clinical Human Tissue Studies
Pre-clinical Human Tissue Studies
Our focus is on providing quality pre-clinical human insights into drug efficacy,
giving you more confidence in taking your lead candidates to clinical trials.
Cerebral Organoids
Cerebral Organoids
Our flagship assays provide efficacy measurements of neurological drugs in our 3D human brain tissue models. We evaluate Electrophysiological Responsiveness, Toxicity Screening and Cell Viability, Target validation and single-cell mechanisms.
Stem Cell and Neuronal Cultures
Stem Cell and Neuronal Cultures
We profile cell growth and development in cell monolayers to assess toxicity-related markers of drug effect. This encompasses Mitochondrial Functional Assays, Neurotoxicity and Cell Viability, ATP Content Assays.
Additional Support
Additional Support
Our team is ready to tackle any specific challenges you are facing in characterizing your drug response. Get in touch today to see how we can help.
Page updated
Report abuse